U.S. drugmaker Eli Lilly said is it seeking emergency use authorization from the FDA for its experimental COVID-19 antibody monotherapy and plans to pursue a similar approval for a combination therapy with two of its antibody drugs next month.
Subscribe: [ Ссылка ]
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: [ Ссылка ]
Follow Reuters on Facebook: [ Ссылка ]
Follow Reuters on Twitter: [ Ссылка ]
Follow Reuters on Instagram: [ Ссылка ]
![](https://s2.save4k.ru/pic/bWnupZj5PJo/maxresdefault.jpg)